EMEA-000463-PIP01-08-M03
Key facts
Invented name |
Glivec
|
Active substance |
imatinib mesilate
|
Therapeutic area |
Oncology
|
Decision number |
P/0028/2012
|
PIP number |
EMEA-000463-PIP01-08-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Novartis Europharm Limited
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000463-PIP01-08-M03
|
Compliance opinion date |
09/03/2012
|
Compliance outcome |
positive
|